Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNon-Current Deferred Tax LiabilityOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)Property, Plant & Equipment (Net)ReceivablesReceivables - NetRetained EarningsShareholder's EquityShares OutstandingShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

GeneDx Holdings (WGS) Treasury Shares (2021 - 2026)

GeneDx Holdings has reported Treasury Shares over the past 6 years, most recently at $1.7 million for Q1 2026.

  • Quarterly Treasury Shares fell 8.06% to $1.7 million in Q1 2026 from the year-ago period, while the trailing twelve-month figure was $1.7 million through Mar 2026, down 8.06% year-over-year, with the annual reading at $1.5 million for FY2025, 18.71% down from the prior year.
  • Treasury Shares was $1.7 million for Q1 2026 at GeneDx Holdings, up from $1.5 million in the prior quarter.
  • Over five years, Treasury Shares peaked at $23.7 million in Q3 2022 and troughed at $855061.0 in Q4 2022.
  • The 5-year median for Treasury Shares is $1.8 million (2025), against an average of $4.9 million.
  • Year-over-year, Treasury Shares plummeted 93.21% in 2022 and then skyrocketed 76.35% in 2023.
  • A 5-year view of Treasury Shares shows it stood at $855061.0 in 2022, then skyrocketed by 76.35% to $1.5 million in 2023, then grew by 23.99% to $1.9 million in 2024, then fell by 18.71% to $1.5 million in 2025, then rose by 8.72% to $1.7 million in 2026.
  • Per Business Quant, the three most recent readings for WGS's Treasury Shares are $1.7 million (Q1 2026), $1.5 million (Q4 2025), and $1.6 million (Q3 2025).